Urology · Sanborn, NY
NPI
1902061914
Since 2008
Specialty
Urology
Code 208800000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
3850 Saunders Settlement Rd
Sanborn, NY, 14132
Phone (716) 898-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$284K
9,396 services
Medicare patients, 2024
789
Average age 73
Drug cost, 2024
$13.3M
3,969 prescriptions
Company payments, 2025
$989
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Rutkowski was code J1952 (leuprolide injectable, camcevi, 1 mg), 882 times for 16 patients. In total John M Rutkowski billed 9,396 services in 92 codes, and Medicare paid $284K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 882 | 16 | $44.91 | $40K |
| 81003 Clinical Chemistry | Office | 800 | 527 | $2.16 | $1,731 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 736 | 511 | $10.86 | $7,995 |
| 99214 Office E&M - Established | Office | 470 | 346 | $84.07 | $40K |
| 99213 Office E&M - Established | Office | 326 | 278 | $57.92 | $19K |
| 36415 Venipuncture Blood Collection | Office | 187 | 159 | $7.82 | $1,462 |
| 51798 Ultrasound - Nonspecific | Office | 162 | 131 | $7.56 | $1,225 |
| 84153 Clinical Chemistry | Office | 128 | 110 | $18.02 | $2,307 |
| 52000 Cystourethroscopy | Facility | 89 | 79 | $52.83 | $4,701 |
| 99204 Office E&M - New | Office | 63 | 63 | $107.81 | $6,792 |
| 77014 Conventional Radiation Treatment | Office | 50 | 23 | $86.69 | $4,335 |
| G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 49 | 23 | $255.04 | $12K |
| 99204 Office E&M - New | Facility | 44 | 44 | $104.70 | $4,607 |
| 99441 Telephone Services | Office | 34 | 31 | $36.61 | $1,245 |
| 84154 Clinical Chemistry | Office | 30 | 22 | $18.02 | $541 |
By year: 2022 $245K for 7,506 services; 2023 $277K for 7,334 services; 2024 $284K for 9,396 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 800 | 527 | $2.16 | $1,731 |
| 36415 Venipuncture Blood Collection | 187 | 159 | $7.82 | $1,462 |
| 84153 Clinical Chemistry | 128 | 110 | $18.02 | $2,307 |
| 84154 Clinical Chemistry | 30 | 22 | $18.02 | $541 |
Medicare prescription drug claims, 2024
In 2024, the drug John M Rutkowski prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 633 prescriptions and refills. In total John M Rutkowski wrote 3,969 Medicare prescriptions that cost $13.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 633 | 635 | 86 | $8.0M |
| Tamsulosin Hcl Generic | 599 | 1,262 | 178 | $11K |
| Prednisone Generic | 417 | 425 | 75 | $2,608 |
| Abiraterone Acetate Generic | 400 | 406 | 68 | $1.2M |
| Finasteride Generic | 355 | 886 | 100 | $5,719 |
| Myrbetriq Mirabegron | 268 | 453 | 87 | $199K |
| Nubeqa Darolutamide | 244 | 244 | 43 | $3.2M |
| Alfuzosin Hcl Er Alfuzosin Hcl | 84 | 195 | 30 | $2,088 |
| Ciprofloxacin Hcl Generic | 74 | 74 | 66 | $280 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 73 | 73 | 67 | $193 |
| Potassium Citrate Er Potassium Citrate | 52 | 86 | 15 | $3,288 |
| Orgovyx Relugolix | 47 | 47 | Under 11 | $122K |
| Cephalexin Generic | 47 | 87 | 22 | $611 |
| Estradiol Generic | 46 | 85 | 26 | $3,448 |
| Solifenacin Succinate Generic | 40 | 60 | Under 11 | $764 |
Brand drugs: 1,279 claims; generic drugs: 2,690 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John M Rutkowski $989 ($989 in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $314.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 11 | $314 |
| Astellas Pharma US Inc 4503.T | 7 | $254 |
| Boston Scientific Corporation BSX | 2 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $119 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $35.95 |
| Acera Surgical, Inc. | 1 | $29.61 |
| Calyxo, Inc. | 1 | $25.37 |
| Pfizer Inc. PFE | 1 | $19.58 |
| Ferring Pharmaceuticals Inc. | 1 | $19.52 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $17.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.